Calculation For Roma Using Roche Elecsys Method

What is the ROMA Score?

The **calculation for ROMA using Roche Elecsys method** refers to the Risk of Ovarian Malignancy Algorithm (ROMA), a dual-marker blood test that helps determine the likelihood of finding epithelial ovarian cancer in women with a pelvic mass. It is not a standalone diagnostic test but a risk stratification tool designed to be used alongside clinical and radiological assessments to guide patient management.

ROMA combines the measurements of two biomarkers—Human Epididymis Protein 4 (HE4) and Cancer Antigen 125 (CA 125)—with the patient’s menopausal status to generate a numerical score. This score classifies women into a “low-risk” or “high-risk” group for malignancy, aiding physicians in deciding whether to refer the patient to a gynecologic oncologist for specialized care. A common misunderstanding is that ROMA diagnoses cancer; it only assesses statistical risk.

The {primary_keyword} Formula and Explanation

The ROMA algorithm uses different formulas to calculate a Predictive Index (PI) based on whether a woman is pre-menopausal or post-menopausal. The PI is then used to calculate the final ROMA score as a percentage.

Predictive Index (PI) Formulas:

Pre-menopausal: PI = -12.0 + 2.38 * LN(HE4) + 0.0626 * LN(CA125)
Post-menopausal: PI = -8.09 + 1.04 * LN(HE4) + 0.732 * LN(CA125)

Final ROMA Score Formula:

ROMA Score (%) = ( e^PI / (1 + e^PI) ) * 100

Variables Used in the ROMA Calculation
Variable	Meaning	Unit	Typical Range (for calculation)
HE4	Human Epididymis Protein 4 level	pmol/L	10 – 1500
CA 125	Cancer Antigen 125 level	U/mL	5 – 5000
LN	Natural Logarithm	Unitless	N/A
PI	Predictive Index	Unitless	Calculated value

Practical Examples

Example 1: Pre-menopausal Patient

A 45-year-old pre-menopausal woman presents with a pelvic mass. Her bloodwork, using the Roche Elecsys method, shows:

Inputs:
- Menopausal Status: Pre-menopausal
- HE4: 65 pmol/L
- CA 125: 80 U/mL
Calculation:
- PI = -12.0 + 2.38 * LN(65) + 0.0626 * LN(80) = -12.0 + 9.94 + 0.27 = -1.79
- ROMA (%) = (exp(-1.79) / (1 + exp(-1.79))) * 100 = 14.3%
Result:
- The ROMA score is 14.3%. For pre-menopausal women, a score ≥ 11.4% is considered high risk. This result suggests a referral to a gynecologic oncologist is warranted.

Example 2: Post-menopausal Patient

A 62-year-old post-menopausal woman is evaluated for an adnexal mass. Her biomarker results are:

Inputs:
- Menopausal Status: Post-menopausal
- HE4: 90 pmol/L
- CA 125: 150 U/mL
Calculation:
- PI = -8.09 + 1.04 * LN(90) + 0.732 * LN(150) = -8.09 + 4.68 + 3.67 = 0.26
- ROMA (%) = (exp(0.26) / (1 + exp(0.26))) * 100 = 56.5%
Result:
- The ROMA score is 56.5%. For post-menopausal women, a score ≥ 29.9% indicates high risk. This high score strongly supports the need for specialist consultation.

How to Use This {primary_keyword} Calculator

Select Menopausal Status: Choose either “Pre-menopausal” or “Post-menopausal” from the dropdown menu. This is critical as it changes the formula used for the calculation.
Enter HE4 Value: Input the patient’s HE4 level in pmol/L. Ensure this value is from a Roche Elecsys assay for accuracy.
Enter CA 125 Value: Input the patient’s CA 125 level in U/mL, also from a Roche Elecsys assay.
Review the Results: The calculator will instantly display the final ROMA Score (%), the intermediate Predictive Index (PI), and the applicable risk threshold. A visual chart will also show the score relative to the high-risk cutoff.
Interpret the Score: Compare the calculated ROMA score to the threshold provided. A score at or above the threshold places the patient in the high-risk category for epithelial ovarian cancer.

Key Factors That Affect {primary_keyword}

Several factors can influence the biomarker levels and therefore the final ROMA score:

Menopausal Status: This is a primary factor, with different formulas and risk cutoffs for pre- and post-menopausal women.
Age: HE4 levels naturally tend to increase with age, which is partly why the post-menopausal thresholds are different.
Benign Gynecologic Conditions: Conditions like endometriosis, fibroids, and pelvic inflammatory disease can elevate CA 125 levels, potentially leading to a higher score in the absence of malignancy.
Kidney Function: Impaired renal function can lead to elevated HE4 levels, as the kidneys are involved in its clearance. This must be considered during interpretation.
Smoking: Some studies suggest that smoking can affect HE4 levels, adding another variable to consider.
Assay Method: The ROMA calculation is specifically validated for the Roche Elecsys method. Using values from other manufacturers’ assays can lead to inaccurate results.

Frequently Asked Questions (FAQ)

1. What is considered a high ROMA score?

A high score depends on menopausal status. Using the Roche Elecsys assays, the cutoffs are typically ≥11.4% for pre-menopausal women and ≥29.9% for post-menopausal women.

2. Does a high ROMA score mean I have cancer?

No. The ROMA score is a risk assessment tool, not a diagnosis. A high score indicates a greater statistical likelihood of malignancy and means further evaluation by a specialist is highly recommended.

3. What are HE4 and CA 125?

HE4 (Human Epididymis Protein 4) and CA 125 (Cancer Antigen 125) are proteins that can be measured in the blood. They are known as tumor markers because their levels are often elevated in the presence of certain cancers, particularly epithelial ovarian cancer.

4. Why is menopausal status so important for the calculation?

Hormonal changes and age affect the baseline levels of HE4 and CA 125. Separate formulas and cutoffs for pre- and post-menopausal women are necessary to maintain the test’s accuracy.

5. Can this calculator be used for general ovarian cancer screening?

No. The ROMA test is not a screening tool for the general population. It is specifically indicated for women who already have a diagnosed pelvic or adnexal mass to help assess the risk of that mass being malignant.

6. What are the units required for this calculator?

The calculator requires HE4 values in picomoles per liter (pmol/L) and CA 125 values in units per milliliter (U/mL), which are the standard units for the Roche Elecsys assays.

7. What happens after a high ROMA score?

A high score typically leads to a referral to a gynecologic oncologist. This specialist will conduct a more thorough evaluation, which may include advanced imaging and, ultimately, surgery to remove the mass and determine its nature through histology.

8. Are there limitations to the calculation for ROMA using Roche Elecsys method?

Yes. The score can be influenced by benign conditions, kidney disease, and age. It has not been validated for women who are pregnant, under 18, or have been previously treated for malignancy. It must always be interpreted in the context of a full clinical workup.

Related Tools and Internal Resources

For more health and medical calculations, explore our other tools:

ROMA Score Calculator (Roche Elecsys Method)